Wataru Takahashi1, Shota Oshikawa1, Shinichiro Mori2. 1. Technology Research Laboratory, Shimadzu Corporation, Kyoto, 619-0237, Japan. 2. Research Center for Charged Particle Therapy, National Institute of Radiological Sciences, Chiba, 263-8555, Japan.
Abstract
OBJECTIVE: For real-time markerless tumour tracking in stereotactic lung radiotherapy, we propose a different approach which uses patient-specific deep learning (DL) using a personalised data generation strategy, avoiding the need for collection of a large patient data set. We validated our strategy with digital phantom simulation and epoxy phantom studies. METHODS: We developed lung tumour tracking for radiotherapy using a convolutional neural network trained for each phantom's lesion by using multiple digitally reconstructed radiographs (DRRs) generated from each phantom's treatment planning four-dimensional CT. We trained tumour-bone differentiation using large numbers of training DRRs generated with various projection geometries to simulate tumour motion. We solved the problem of using DRRs for training and X-ray images for tracking using the training DRRs with random contrast transformation and random noise addition. RESULTS: We defined adequate tracking accuracy as the percentage frames satisfying <1 mm tracking error of the isocentre. In the simulation study, we achieved 100% tracking accuracy in 3 cm spherical and 1.5×2.25×3 cm ovoid masses. In the phantom study, we achieved 100 and 94.7% tracking accuracy in 3 cm and 2 cm spherical masses, respectively. This required 32.5 ms/frame (30.8 fps) real-time processing. CONCLUSIONS: We proved the potential feasibility of a real-time markerless tumour tracking framework for stereotactic lung radiotherapy based on patient-specific DL with personalised data generation with digital phantom and epoxy phantom studies. ADVANCES IN KNOWLEDGE: Using DL with personalised data generation is an efficient strategy for real-time lung tumour tracking.
OBJECTIVE: For real-time markerless tumour tracking in stereotactic lung radiotherapy, we propose a different approach which uses patient-specific deep learning (DL) using a personalised data generation strategy, avoiding the need for collection of a large patient data set. We validated our strategy with digital phantom simulation and epoxy phantom studies. METHODS: We developed lung tumour tracking for radiotherapy using a convolutional neural network trained for each phantom's lesion by using multiple digitally reconstructed radiographs (DRRs) generated from each phantom's treatment planning four-dimensional CT. We trained tumour-bone differentiation using large numbers of training DRRs generated with various projection geometries to simulate tumour motion. We solved the problem of using DRRs for training and X-ray images for tracking using the training DRRs with random contrast transformation and random noise addition. RESULTS: We defined adequate tracking accuracy as the percentage frames satisfying <1 mm tracking error of the isocentre. In the simulation study, we achieved 100% tracking accuracy in 3 cm spherical and 1.5×2.25×3 cm ovoid masses. In the phantom study, we achieved 100 and 94.7% tracking accuracy in 3 cm and 2 cm spherical masses, respectively. This required 32.5 ms/frame (30.8 fps) real-time processing. CONCLUSIONS: We proved the potential feasibility of a real-time markerless tumour tracking framework for stereotactic lung radiotherapy based on patient-specific DL with personalised data generation with digital phantom and epoxy phantom studies. ADVANCES IN KNOWLEDGE: Using DL with personalised data generation is an efficient strategy for real-time lung tumour tracking.
Authors: Jennifer Dhont; Dirk Verellen; Kenneth Poels; Koen Tournel; Manuela Burghelea; Thierry Gevaert; Christine Collen; Benedikt Engels; Robbe Van Den Begin; Nico Buls; Gert Van Gompel; Toon Van Cauteren; Guy Storme; Mark De Ridder Journal: Radiother Oncol Date: 2015-09-03 Impact factor: 6.280
Authors: Hendrik Teske; Paul Mercea; Michael Schwarz; Nils H Nicolay; Florian Sterzing; Rolf Bendl Journal: Med Phys Date: 2015-05 Impact factor: 4.071
Authors: Chun-Chien Shieh; Vincent Caillet; Michelle Dunbar; Paul J Keall; Jeremy T Booth; Nicholas Hardcastle; Carol Haddad; Thomas Eade; Ilana Feain Journal: Phys Med Biol Date: 2017-03-21 Impact factor: 3.609
Authors: Marco Mueller; Per Poulsen; Rune Hansen; Wilko Verbakel; Ross Berbeco; Dianne Ferguson; Shinichiro Mori; Lei Ren; John C Roeske; Lei Wang; Pengpeng Zhang; Paul Keall Journal: Med Phys Date: 2021-12-29 Impact factor: 4.071